133 related articles for article (PubMed ID: 8931494)
1. Radiolabeled ligands specific for the G protein-coupled state of neurotensin receptors.
Gaudriault G; Zsürger N; Vincent JP
J Neurochem; 1996 Dec; 67(6):2590-8. PubMed ID: 8931494
[TBL] [Abstract][Full Text] [Related]
2. Compared binding properties of 125I-labeled analogues of neurotensin and neuromedin N in rat and mouse brain.
Gaudriault G; Zsürger N; Vincent JP
J Neurochem; 1994 Jan; 62(1):361-8. PubMed ID: 8263537
[TBL] [Abstract][Full Text] [Related]
3. Selective labeling of alpha- or epsilon-amino groups in peptides by the Bolton-Hunter reagent.
Gaudriault G; Vincent JP
Peptides; 1992; 13(6):1187-92. PubMed ID: 1283630
[TBL] [Abstract][Full Text] [Related]
4. Agonist properties of a stable hexapeptide analog of neurotensin, N alpha MeArg-Lys-Pro-Trp-tLeu-Leu (NT1).
Akunne HC; Demattos SB; Whetzel SZ; Wustrow DJ; Davis DM; Wise LD; Cody WL; Pugsley TA; Heffner TG
Biochem Pharmacol; 1995 Apr; 49(8):1147-54. PubMed ID: 7748196
[TBL] [Abstract][Full Text] [Related]
5. Agonist and antagonist modulation of [35S]-GTP gamma S binding in transfected CHO cells expressing the neurotensin receptor.
Hermans E; Geurts M; Maloteaux JM
Br J Pharmacol; 1997 Aug; 121(8):1817-23. PubMed ID: 9283723
[TBL] [Abstract][Full Text] [Related]
6. Chicken liver contains a large quantity of a G-protein-linked neurotensin receptor.
Mitra SP; Carraway RE
Peptides; 1995; 16(3):471-7. PubMed ID: 7651901
[TBL] [Abstract][Full Text] [Related]
7. Novel neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors.
Alshoukr F; Rosant C; Maes V; Abdelhak J; Raguin O; Burg S; Sarda L; Barbet J; Tourwé D; Pelaprat D; Gruaz-Guyon A
Bioconjug Chem; 2009 Aug; 20(8):1602-10. PubMed ID: 19610615
[TBL] [Abstract][Full Text] [Related]
8. Neurotensin modulates the electrical activity of frog pituitary melanotropes via activation of a G-protein-coupled receptor pharmacologically related to both the NTS1 and nts2 receptors of mammals.
Belmeguenai A; Vaudry H; Leprince J; Vivet B; Cavelier F; Martinez J; Louiset E
Neuroendocrinology; 2000 Dec; 72(6):379-91. PubMed ID: 11146421
[TBL] [Abstract][Full Text] [Related]
9. Biodistribution and catabolism of (18)F-labeled neurotensin(8-13) analogs.
Bergmann R; Scheunemann M; Heichert C; Mäding P; Wittrisch H; Kretzschmar M; Rodig H; Tourwé D; Iterbeke K; Chavatte K; Zips D; Reubi JC; Johannsen B
Nucl Med Biol; 2002 Jan; 29(1):61-72. PubMed ID: 11786277
[TBL] [Abstract][Full Text] [Related]
10. The signaling signature of the neurotensin type 1 receptor with endogenous ligands.
Besserer-Offroy É; Brouillette RL; Lavenus S; Froehlich U; Brumwell A; Murza A; Longpré JM; Marsault É; Grandbois M; Sarret P; Leduc R
Eur J Pharmacol; 2017 Jun; 805():1-13. PubMed ID: 28341345
[TBL] [Abstract][Full Text] [Related]
11. Impaired G protein coupling of the neurotensin receptor 1 by mutations in extracellular loop 3.
Richard F; Barroso S; Nicolas-Ethève D; Kitabgi P; Labbé-Jullié C
Eur J Pharmacol; 2001 Dec; 433(1):63-71. PubMed ID: 11755135
[TBL] [Abstract][Full Text] [Related]
12. Interaction of the COOH-terminal domain of the neurotensin receptor with a G protein does not control the phospholipase C activation but is involved in the agonist-induced internalization.
Hermans E; Octave JN; Maloteaux JM
Mol Pharmacol; 1996 Feb; 49(2):365-72. PubMed ID: 8632771
[TBL] [Abstract][Full Text] [Related]
13. Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor.
Gully D; Canton M; Boigegrain R; Jeanjean F; Molimard JC; Poncelet M; Gueudet C; Heaulme M; Leyris R; Brouard A
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):65-9. PubMed ID: 8380498
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of a biologically active fluorescent probe for labeling neurotensin receptors.
Faure MP; Gaudreau P; Shaw I; Cashman NR; Beaudet A
J Histochem Cytochem; 1994 Jun; 42(6):755-63. PubMed ID: 8189037
[TBL] [Abstract][Full Text] [Related]
15. Neurotensin receptors: binding properties, transduction pathways, and structure.
Vincent JP
Cell Mol Neurobiol; 1995 Oct; 15(5):501-12. PubMed ID: 8719037
[TBL] [Abstract][Full Text] [Related]
16. G-protein-coupled receptor microarrays.
Fang Y; Frutos AG; Lahiri J
Chembiochem; 2002 Oct; 3(10):987-91. PubMed ID: 12362364
[TBL] [Abstract][Full Text] [Related]
17. Structure, functional expression, and cerebral localization of the levocabastine-sensitive neurotensin/neuromedin N receptor from mouse brain.
Mazella J; Botto JM; Guillemare E; Coppola T; Sarret P; Vincent JP
J Neurosci; 1996 Sep; 16(18):5613-20. PubMed ID: 8795617
[TBL] [Abstract][Full Text] [Related]
18. Ontogenesis and binding properties of high-affinity neurotensin receptors in human brain.
Zsürger N; Chabry J; Coquerel A; Vincent JP
Brain Res; 1992 Jul; 586(2):303-10. PubMed ID: 1325861
[TBL] [Abstract][Full Text] [Related]
19. Preparation and binding properties of radioiodinated analogues of dermorphin and deltorphin with high specificity for the mu- and delta-opioid receptors.
Gaudriault G; Zsürger N; Vincent JP
J Neurochem; 1997 Feb; 68(2):813-9. PubMed ID: 9003073
[TBL] [Abstract][Full Text] [Related]
20. Functional properties and molecular structure of central and peripheral neurotensin receptors.
Mazella J; Amar S; Bozou JC; Kitabgi P; Vincent JP
J Recept Res; 1987; 7(1-4):157-65. PubMed ID: 3040976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
